Brief: Black Diamond Therapeutics Q2 EPS $-0.19
07/08/2025 13:37
Aug 7 (Reuters) - Black Diamond Therapeutics Inc BDTX.O: BLACK DIAMOND THERAPEUTICS INC - Q2 EPS $-0.19 BLACK DIAMOND THERAPEUTICS INC - HAS $142.8 MILLION CASH AS OF JUNE 30 TO FUND OPERATIONS INTO Q4 2027 - SEC FILING Source text: [ID:n0001701541-25-000029] Further company coverage: BDTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Black Diamond Therapeutics
See all newsBlack Diamond Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Black Diamond Therapeutics Q2 net loss narrows year over year
Black Diamond Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
Black Diamond Therapeutics Q4 net loss narrows, full-year profit turns positive
U.S. STOCKS ON THE MOVE-Spirit AeroSystems, Boeing, Roblox